Primary amoebic meningoencephalitis is a rare, acute, usually fatal disease of active juveniles (4) . The disease has been encountered throughout the world, and the etiologic agent, Naegleria fowleri, has been isolated from a variety of aquatic environments in both hemispheres (7, 15) . Antibodies reacting with N. fowleri antigens have been detected in pooled sera from young adult women in the United States (16) and in serum samples from adults and infants in New Zealand (5) . Agglutinating activity specific for N. fowleri has also been measured in serum samples from 255 human subjects in Richmond, Va. (12) . The agglutinating activity for N. fowleri could not be absorbed by N. gruberi. Sera from human infants had negligible capability to agglutinate N. fowleri. By 4 years of age, all children tested had sera with measurable agglutinating activity for N. fowleri. Agglutinating activity for N. fowleri rose progressively, reaching a maximum at young adulthood.
It had been observed in the previous surveys that N. fowleri KUL was not agglutinated as effectively by human sera (12) or hyperimmune mouse sera (9) as other tested strains. This discrepancy could be due to inherent antigenic differences or to physiological heterogeneity. We had noted that strain KUL remained more amoeboid in the diluent used for agglutination assays than most other strains. Accordingly, we compared the capability of human serum to agglutinate rounded cells and amoeboid cells of N. fowleri and N. gruberi.
One of the objectives of this study has been to gain insight into the source of antigen eliciting the antibodies reacting with N. fowleri. Cursons et al. (5) proposed that antibodies to Naegleria spp. might have been elicited by exposure to ubiquitous nonpathogenic amoebae such as N. gruberi. Our earlier survey, however, failed to detect agglutinating activity for N. gruberi in human serum (12 primary amoebic meningoencephalitis in humans is rare (4), amoebae have also been implicated in an asthmatic-type disease and rheumatoid arthritis (18) . A second objective of this study was to test for a correlation between antibody to Naegleria spp. and rheumatoid arthritis or asthma. The present survey has assessed the capabilities of cord sera and serum samples from elderly humans to agglutinate Naegleria cells. These subjects had not been included in our prior study (12) (1) . Duplicate assays did not vary by more than one twofold dilution.
Anti-human immunoglobulin A (IgA), IgG, and IgM antisera (Cappel Laboratories, Cochranville, Pa.) were used to identify the immunoglobulin class present in fractions after DEAE-cellulose chromatography and were used as reagents to block agglutinating activity of human serum samples. For the latter purpose, 50 ,ul of a human serum sample and 50 ,ul of antiimmunoglobulin reagent were mixed and incubated at 37°C for 30 min before assaying for agglutinating activity.
Human serum samples were fractionated by DEAEcellulose chromatography (11) . The protein fractions were recovered by stepwise elution with sodium phosphate buffers: step 1, 15 mM, pH 6.3; step II, 40 mM, pH 6.0; step III, 100 mM, pH 5.8; step IV, 300 mM, pH 5.5; and step V, 400 mM, pH 4.3. The protein distribution was monitored with a model UA-5/273 fraction collector (ISCO, Lincoln, Nebr.). The flow rate was 80 to 90 ml/h. Samples corresponding to absorbance peaks were pooled and concentrated by dialysis against polyethylene glycol (Carbowax 20,000; Union Carbide Corp., New York, N.Y.).
Sera and serum samples were treated with 200 mM 2-mercaptoethanol to inactivate 1gM (9) . The treated samples and their untreated controls were incubated at VOL. 17, 1983 on August 27, 2017 by guest http://jcm.asm.org/ Ouchterlony gel diffusion assays were performed on selected sera and serum fractions by the method of Garvey et al. (8) .
RESULTS
The agglutinating capability of 77 serum samples from infants, children, and juveniles and of samples from 226 adults against N. foit'leri nN68
was assessed. The sera of all 15 infants, including 7 cord sera, had negligible agglutination titers against N. fotwleni. The sera of the 22 1-to 4-year-old children had a median agglutination titer of 1:4. Sera of the 120 adolescents and adults had a median agglutination titer of 1:16. Sera of institutionalized subjects in the age range of 60 to 90 years had a median agglutinating titer of 1:8, whereas those living in the community had a median titer of 1:4 ( Table 1) .
The agglutinating titers of sera from 25 rheumatoid factor-positive and 25 rheumatoid factornegative adult arthritis patients were compared. The median titer of the rheumatoid factor-positive sera was 1:8, whereas that for rheumatoid factor-negative patients was 1:16 ( Several human sera were fractionated by DEAE-cellulose chromatography. By Ouchterlony assays, we confirmed that the majority of the IgG was in fraction I and the majority of the IgM was in fraction 4. Essentially all of the agglutinating activity was in fraction 4 ( Fig. 1) . Anti-human IgM but not anti-human IgA or antihuman IgG blocked the ability of human sera to agglutinate N. fow/leri (Table 5 ). The agglutinating activity of whole human serum and of fraction 4 was inactivated by 2-mercaptoethanol. Sera from elderly subjects who had negligible capability to agglutinate N. otw/leri did not inhibit the ability of sera of young adults to agglutinate N. fowvleri.
Selected samples of sera from pediatric outpatients were examined for their capability to agglutinate live or killed rounded cells of N. ftwleri and N. gruberi. The agglutinating activities of the pediatric serum samples measured with killed cells as the assay antigen were essentially the same as those measured with live rounded cells (Table 6 ). There was, however, no correlation between the agglutinating activity of a pediatric serum sample with respect to N. fowvleri and that for N. gruberi. DISCUSSION Our results indicate that humans are periodically exposed to Naegleria immunogen in sufficient amounts to elicit and sustain a readily measurable immune response. The antibody elicited is of the IgM class, indicating that the exposure is rather low or that the antigen may be a repeating polymer, for example, a polysaccharide or glycolipid. The capability of human serum samples to agglutinate rounded cells but not amoebae of N. fowleri or N. gruberi is consistent with the proposition that rounded cells display unique antigenic sites on their surfaces. The agglutinating activities are species specific, thereby corroborating the suggestion that the agglutinating activity for N. fowleri is not the result of prior exposure to the ubiquitous freeliving amoeboflagellate N. gruberi. Moreover, the agglutinating activity is not absorbed by sheep erythrocytes, indicating that Forssman antigens are not involved. Accordingly, N. fowleri itself may be the immunogen eliciting the N. fowleri agglutinins. If this proposal is correct, exposure to N. fowleri only rarely leads to primary amoebic meningoencephalitis.
The failure to detect agglutination of N. gruberi by human serum in our previous survey (12) reflected the rapid reversion to amoeboid cells that occurred during the assay. Good agglutination of either N. fowleri or N. gruberi is achieved only with rounded cells. Rounding is evoked by chilling cells grown in a medium of low ionic strength (e.g., Nelson medium). N. gruberi grown in Balamuth medium reverts rapidly to the amoeboid form and is not suitable for agglutination assays. Rounded cells may be killed and fixed with paraformaldehyde to ensure that they do not revert to the amoeboid form.
Sera from young adult humans contain specific agglutinating activity for N. fowleri, but the agglutinating activity is negligible in infants. The agglutinating activity is an antibody of the 1gM class; therefore, it is not passed transplacentally to newborns. Toddlers develop agglutinating activity, indicating that antigenic exposure is associated with exploration of the environment. Agglutinating activity is highest in the sera of young adults and wanes in later life. Although impaired responsiveness to Naegleria antigens is a possible explanation, it is more likely that decreased exposure to the antigen is responsible for the decreased level of agglutinating activity in the sera of humans over 50 years of age. The source of this antigen or cross-reacting antigen in nature remains unknown. N. fowleri can be isolated from nature, particularly from thermally polluted water (7, 15) .
In our previous survey (12) , the 38 asthmatic pediatric outpatients appeared to have somewhat higher agglutination titers with respect to N. fowleri than nonasthmatic children of similar age (median of 1:16 versus median of 1:8, respectively). In the current series of 22 asthmatic pediatric outpatients, the agglutinating activity for N. fowleri was the same as that for other 
